Product Information
Registration Status: ActiveSIN14398P
JAKAVI TABLET 20MG is approved to be sold in Singapore with effective from 2013-08-22. It is marketed by NOVARTIS (SINGAPORE) PTE LTD, with the registration number of SIN14398P.
This product contains Ruxolinitib 20mg in the form of TABLET. It is approved for ORAL use.
This product is manufactured by Novartis Pharma Stein AG
Allpack Group AG (primary in SWITZERLAND.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.